Search Results for "Ranbaxy Launches Atorvastatin In Us"

16:17 EDT 28th May 2017 | BioPortfolio

Matching Channels


Matching News

FDA To Lift Ban On Ranbaxy Plant; Good News For Sun Compliance Push?

A US FDA ban on Sun Pharma’s Mohali site, a legacy Ranbaxy facility, is set to be lifted, marking a...   

Two medical journals publish retractions on two papers related to atorvastatin, brain bleeding

Body: Two medical journals recently retracted a pair of papers about the possible use of atorvastatin to treat bleeding on the brain, Retraction Watch reports. The website noted that the papers w...

Lost $700m Opportunity As PTC Bids Farewell to Translarna in CF

In withdrawing its European marketing application for Translarna in cystic fibrosis, PTC Therapeutics has bid farewell to a market opportunity...   

Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth

Esperion Announces Initiation Of Phase II Triplet Oral Therapy Study Of Bempedoic Acid/Ezetimibe/Atorvastatin

  Life Sciences Jobs   ...

Esperion Announces Initiation Of Phase 2 Triplet Oral Therapy Study Of Bempedoic Acid/Ezetimibe/Atorvastatin

  Life Sciences Jobs   ...

'Suggestion' of Brain Changes on Statins by fMRI in STOMP

Despite few differences at cognitive testing for patients on atorvastatin vs placebo in the STOMP substudy, "small but significant" neuronal changes were seen on statins, their meaning uncle...

North Korea Missiles Launches: A Timeline

This year, so far, the reclusive nation has carried missile launches thrice.

Matching PubMed Articles

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.

Objective Compared the effect of atorvastatin 10 mg combined ezetimibe 10 mg therapy with atorvastatin 20 mg on the long-term outcomes in very elderly patients with acute coronary syndrome.Methods A t...

Atorvastatin Can Ameliorate Left Atrial Stunning Induced by Radiofrequency Ablation for Atrial Fibrillation.

The objective of this study was to study the functional changes of left atrium after radiofrequency ablation treatment for atrial fibrillation and the therapeutic effect of Atorvastatin. 58 patients u...

Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro.

Contrast-induced nephropathy (CIN) is an iatrogenic acute renal failure occurring following the intravascular injection of iodinated radiographic contrast medium. However, the regulatory mechanisms fo...

The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study.

Publicly-funded atorvastatin required prior approval until September 2010 whereas simvastatin did not. Our aim was to examine if overall statin dispensing and atorvastatin dispensing among patients ho...

Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease.

Atorvastatin decreases blood lipids but is associated with side effects. Zhibitai is a traditional Chinese medicine used to treat blood lipid disorders. The objective of this study is to evaluate the ...

Search Whole site using Google

Quick Search
Advertisement Advertisement